Brought to you by

Novartis acquires BMS's US and Canadian consumer drug unit
03 Aug 2005
Executive Summary
Novartis has acquired Bristol-Myers Squibb's US and Canadian consumer medicines business unit for $660mm in cash.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com